Intravitreal Anti-VEGF Injections in Pregnancy: Case Series and Review of Literature.

Abstract

The use of intravitreal antivascular endothelial growth factor (anti-VEGF) injection is gaining wide acceptance as an off-label therapy for diseases that may affect pregnant women. However, these drugs may cause systemic side effects in the mother and fetal harm. This could lead specialists to not administer the drug or women to abort the fetus or to refuse… (More)
DOI: 10.1089/jop.2015.0056

Topics

1 Figure or Table

Cite this paper

@article{Polizzi2015IntravitrealAI, title={Intravitreal Anti-VEGF Injections in Pregnancy: Case Series and Review of Literature.}, author={Silvio Polizzi and Vinit B. Mahajan}, journal={Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics}, year={2015}, volume={31 10}, pages={605-10} }